Michael Sapienza, Chief Executive Officer of Colorectal Cancer Alliance, shared on LinkedIn:
“The Colorectal Cancer Alliance and Takeda recently collaborated on a survey examining the experiences and unmet needs of patients diagnosed with metastatic colorectal cancer in the United States. We’re proud to share that the findings have been published in Future Oncology.
The research reflects an important principle: understanding cancer requires more than clinical outcomes alone. We also need to understand what patients experience throughout diagnosis and treatment, where they encounter gaps in care, and what needs remain unmet.
These perspectives can help researchers, healthcare professionals, and patient advocacy organizations ask better questions about how care is delivered and where it needs to improve.
At the Colorectal Cancer Alliance, elevating the patient voice is central to our work. Patient-centered research means listening systematically, examining what patients tell us, and using those insights to inform the questions we pursue and the support we provide.
Publishing this research is another important step. The findings are available for researchers, clinicians, advocates, and others to read and build on, extending the potential reach of the work beyond the original study.
I’m grateful to our partners at Takeda and everyone who contributed to this research.
We must continue creating opportunities for patients’ experiences to inform not only how we communicate about cancer, but also how we work to improve care.”
You may also be interested in:
Michael Sapienza Joins Guardant Health’s High Table to Discuss the Future of Cancer Screening
Pelé’s Cause of Death: Brazilian Football King’s Battle With Colon Cancer